Chi Podcasts

Caroline Bennette of the Group Health Research Institute speaks to CHI on April 3, 2015. Dr. Bennette will be a presenter at TCGC: The Clinical Genome Conference, June 22-24 in San Francisco, CA. Topics include determining the cost effectiveness of returning incidental findings from next-generation sequencing to patients, challenges faced when developing analytic tools and policy models to aid decision-making in oncology and Patient-Centered Outcomes Research at the Group Health Research Institute. For more information visit http://www.ClinicalGenomeConference.com/

James L. Sherley of Asymmetrex (launched in 2013 as “The Adult Stem Cell Technology Center (ASCTC)”) speaks to CHI on March 16, 2015. Dr. Sherley will be presenting during the 3D Cellular Models conference at the 2015 World Preclinical Congress, June 10-12 in Boston, MA. Topics include asymmetric self-renewal of tissue stem cells, p53 regulation, stem cell kinetics dynamics and the dimension of time, incorporating cell turnover into 3D cellular models, and combining computer simulation and primary tissue cell culture for drug toxicity research.

Krista Woodley of Biogen speaks to CHI on March 12, 2015. Ms. Woodley will be presenting during the Cloud Computing and Data Security tracks at Bio-IT World Conference & Expo, April 21-23 in Boston, MA. Topics include IT risk management and regulatory compliance in the life sciences, how the rise of cloud-based computing has altered data security management, compliant cloud computing and more.

Elizabeth D. Buttermore of Boston Children's Hospital and Harvard Medical School speaks to CHI on March 27, 2015. Dr. Buttermore will be presenting during the 3D Cellular Models conference at the 2015 World Preclinical Congress, June 10-12 in Boston, MA. Topics include how human-derived neurons enhance preclinical phenotypic screening, heterologous expression systems, translational research and the potential of pain models and peripheral neuropathy research for drug development. Find more at http://www.WorldPharmaCongress.com/

Nathaniel Pearson of the New York Genome Center speaks to CHI on March 17, 2015. Dr. Pearson will be a keynote presenter at TCGC: The Clinical Genome Conference, June 22-24 in San Francisco, CA. Topics include biological and genomic diversity, the evolution of systems over time, the New York Genome Center’s leveraging of citizen data, the value of participatory science on genomic research, applying big data management lessons from other fields to genomics for long-term healthcare and more. For more information visit http://www.ClinicalGenomeConference.com/

CHI sits down with Dr. Mike Makrigiorgos of Dana Farber and Brigham to discuss a new COLD-PCR method (temperature tolerant COLD-PCR) that uses targeted re-sequencing to detect mutations as low as .01-.1%. In this podcast, Dr. Makrigiorgos discusses the science behind COLD PCR, gives a preview of his talk at the April cfDNA conference in Lisbon, and discusses the future impact of liquid biopsy.

Laura J. van ’t Veer of University of California, San Francisco speaks to CHI on March 4, 2015. Dr. van ‘t Veer will be a keynote presenter at TCGC: The Clinical Genome Conference, June 22-24 in San Francisco, CA. Topics include the genetic makeup of breast cancer tumors and personalized medicine; transdisciplinary research collaborations related to the MammaPrint test; molecular genomic data integration, cancer patient therapy and survival prediction. For more information visit http://www.ClinicalGenomeConference.com/

John Conley of UNC and Robinson Bradshaw & Hinson speaks to CHI on March 3, 2015. Dr. Conley will be presenting during the IT Infrastructure – Hardware, Software Development, Cloud Computing and Data Security tracks at Bio-IT World Conference & Expo, April 21-23 in Boston, MA. Topics include data security and privacy at large health research institutes vs. smaller biotech companies, plus changes to international data privacy regulations and differences between the U.S. and European Union. Find more at: http://www.Bio-ITWorldExpo.com/

This podcast presents an interview with Dr. John Kellie, an Investigator in the Bioanalytical Sciences and Toxicokinetics group at GlaxoSmithKline, and a speaker in the Characterization of Biotherapeutics meeting at the 11th Annual PEGS Boston. John explains how next-generation analytical technologies are being used to characterize circulating ADC species, and how these findings support the development of safe and effective antibody-drug conjugate therapeutics. To learn more, visit http://www.PEGSummit.com/Biotherapeutics-Characterization

Mimi Langley interviews Dr. Jon Lai, Associate Professor at Albert Einstein College of Medicine on February 4. Dr. Lai will be speaking during the Phage & Yeast Display conference at PEGS China Summit, taking place March 31-April 2 in Shanghai, China.

Dave Peterson of Kaiser Permanente speaks to CHI on February 3, 2015. Mr. Peterson will be a panelist during the IT Infrastructure – Hardware, Software Development, Cloud Computing and Data Security tracks at Bio-IT World Conference & Expo, April 21-23 in Boston, MA. Topics include IT compliance and managing vendor-related data security risks, the value of regulations alongside technological innovation, balancing patient privacy with biological research needs, reporting on controls effectiveness for service providers and more. http://www.Bio-ITWorldExpo.com/

David Barton will discuss the new regulations being developed, which have major implications for IVD manufacturers and for laboratory-developed tests. This podcast will give an overview of the proposed new IVD regulation, a timeline for development, and briefly discuss how it will impact IVD manufacturers and clinical labs.

Dr. Mark Gerstein of Yale University speaks to CHI on January 16, 2015. Dr. Gerstein will be a speaker during the Clinical Genomics track at Bio-IT World Conference & Expo, April 21-23, 2015 in Boston, MA. Topics include evolving data science applications to genomics, the utility of networks for biological data analysis and integration, studying non-coding mutations for cancer genomics and personal genomics research, the computational tool FunSeq and more. http://www.bio-itworldexpo.com/

CHI's Samantha Lewis speaks with Daniel Kerls, director of ambulatory operations at CVS' Minute Clinic, as well as Alexander Sbordone, who is the Minute Clinic operations manager at CVS. Kerls and Sbordone discuss staffing MinuteClinic, the types of diagnostic tests they seek out, and the future direction of rapid clinics. Connect with CVS MinuteClinic’s Operations Manager, Alexander Sbordone, for an update on the challenges and expanding opportunities for testing in a retail pharmacy setting at the 2015 Next Generation Dx Summit. For details, visit http://www.nextgenerationdx.com/pharmacy-diagnostics

Amid Zand Interview Ms. Nariman Nasser of Genentech, on December 23, 2014. Nariman will be speaking at the SCOPE Summit in Orlando, FL in a track titled managing late stage research, observational studies and registries. Her talk will focus on digital strategies that makes observational studies more accessible and better aligned with patients lives.

Amid Zand Interview Dr. Vera Ehrenstein of Aarhus University (Denmark) on December 27, 2014. Dr. Ehrenstein will be speaking at the SCOPE Summit in Orlando, FL in a track titled managing late stage research, observational studies and registries. Her talk will focus on collaborating with regulatory bodies such as the EMA on risk-minimization studies.

The University of Pittsburgh Medical Center’s Liron Pantanowitz, Douglas Hartman, and Jeffrey Fine discuss the future of digital pathology, what they are most looking forward to at CHI’s Digital Pathology conference, changes in the field, highlights from their presentations in February, as well as how UPMC has become a leading organization in digital pathology.

Interview with Moderator of the Inaugural Swimming with the Sharks competition, for start-ups to compete for venture funding in the genomic space.

Amid Zand Interview Dr. Sundos Hamza of InterMune on December 12, 2014. In this interview Dr. Hamza speaks about the importance of effective global drug safety risk minimization strategies in clinical and post marketing phases of drug development.

Dr. Lois Lampson, an Associate Professor of Neurosurgery at Brigham and Women’s Hospital, describes novel ways of approaching the targeting of the brain (and brain cancers) using Antibody Therapeutics. Dr. Lampson is a speaker in the Cancer Targets for Antibody Therapeutics meeting being held at the 14th annual Peptalk on January 19-23, 2015 in San Diego. To view speaker abstracts and register for the meeting, please visit http://www.CHI-PepTalk.com